Tatva Chintan Pharma Quarterly Results for Trading Insights
In Mar 2026, Tatva Chintan Pharma (TATVA) reported revenue ₹134 Cr and net profit ₹10 Cr — revenue +22.9% YoY. Also explore TATVA price trends to track price trends across different timeframes.
TATVA Quarterly Results — Revenue, Profit & EPS Highlights
Tatva Chintan Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit TATVA stock price BSE.
- Revenue of ₹134 Cr in Mar 2026 (+7.2% vs Sept 2025, +22.9% vs Mar 2025)
- Net Profit of ₹10 Cr in Mar 2026 (+0.0% vs Sept 2025, +900.0% vs Mar 2025)
- EBITDA of ₹28 Cr in Mar 2026 (+21.7% vs Sept 2025)
- Operating Margin of 21.0% in Mar 2026 (+3.0pp vs Sept 2025)
- Earnings Per Share of ₹4.41 in Mar 2026 (+4.0% vs Sept 2025)
Tatva Chintan Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS
TATVA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 134 | 125 | 109 | 118 | 133 | 7.2% | 22.9% |
| Net Profit (₹ Cr) | 10 | 10 | 1 | 7 | 15 | - | - |
| EBITDA (₹ Cr) | 28 | 23 | 10 | 19 | 27 | - | - |
| EPS (₹) | 4.41 | 4.24 | 0.44 | 2.84 | 6.49 | - | - |
| Operating Margin (%) | 21.0% | 18.0% | 8.0% | 15.0% | 19.0% | - | - |
TATVA Share Price Trend — 1-Year Movement Across Quarterly Results
Tatva Chintan Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with TATVA fair price to assess whether the stock is under or overvalued.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
TATVA vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap
Tatva Chintan Pharma latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Pidilite Industries
Mar 2026 |
₹150,700.65 Cr | 1480.7 | 3,648 | 584 | +1.2% | +13.2% | 16.0% | 260.2 |
|
SRF
Mar 2026 |
₹81,125.55 Cr | 2736.8 | 4,557 | 582 | +28.0% | +7.2% | 12.8% | 139.4 |
|
Linde
Sept 2025 |
₹61,592.27 Cr | 7259.0 | 650 | 171 | +7.4% | - | 26.3% | 362.0 |
|
Fertilisers & Chemi…
Sept 2025 |
₹58,928.84 Cr | 923.4 | 1,681 | 21 | +48.8% | - | 1.2% | 2885.6 |
|
UPL
Mar 2026 |
₹55,390.17 Cr | 656.2 | 18,513 | 1,294 | +49.2% | +18.1% | 7.0% | 52.2 |
All amounts in ₹ Crores